TCS Set for Strong Gains: Motilal Oswal Targets ₹3,000 Amid AI-Driven Transformation Wave
Motilal Oswal has upgraded its outlook on Tata Consultancy Services (TCS), maintaining a 'BUY' rating while setting a high price target of ₹3,000. This target implies a potential 16% upside from the current market price of ₹2,589, underpinned by robust deal wins and strategic positioning in the burgeoning AI landscape.Financial Performance and Valuation Metrics
TCS delivered steady financial results in FY26, reporting a 4QFY26 USD revenue of USD7.6b, reflecting 1.2% QoQ growth in CC terms. The EBIT margin for the fiscal year stood at 25% (FY26), maintaining an industry-leading margin level.The company's Addressable Market Cap is reported at 9367.2 INRb/101.1 USDb. Based on the analysis, the projected Earnings Per Share (EPS) for FY28E is ₹166.7, supporting the valuation model. The current P/E ratio stands at 17.7x, with the projected P/E narrowing to 15.5x by FY28E, indicating potential value accretion.
Analyst Viewpoint: Navigating Growth Patchiness and AI Momentum
Analysts observe that while growth remains patchy, the narrative is shifting strongly towards AI-led transformations. Management highlighted that enterprise spending is channeled through three main buckets: enterprise transformation, AI-led modernization, and pure-play AI transformation.Despite INR depreciation and productivity gains, the firm believes margin expansion will remain underwhelming, expecting margins to stay flat in FY27. The leadership team remains positive about the FY27 outlook, anticipating the first and second quarters to be stronger than 4QFY26, following typical seasonality.
Deal Wins and Key Growth Drivers in AI Sector
A significant catalyst noted by the research team is the momentum in deal acquisitions. TCS announced a deal Total Contract Value (TCV) of USD12b in 4Q, marking a 29% QoQ increase and contributing to an FY26 TCV of USD40.7b.The focus across sectors is clear. For Banking, Financial Services, and Insurance (BFSI), clients prioritize core modernization and scaled AI adoption. Meanwhile, mega deals are noted in US healthcare and pharmacy sectors, underscoring the shift from AI experimentation to industrialized, business-driven transformation.
Operating Metrics and Geographical Stability
The operational data shows continued focus on core strength. Deal mix remains balanced, sourced from roughly 50-55% renewals and 45-50% new programs.Geographically, while the narrative notes that North America remains weak at times, key international markets continue to drive strength. The company also reported a 100MW build-out commitment with OpenAI, signaling tangible progress in AI infrastructure engagements.
Future Outlook and Investor Takeaway
The analyst maintains that while gradual recovery is expected, growth will continue to emerge from select pockets rather than a broad-based uptick. Despite this, the combination of sustained high operational discipline, commitment to investing in talent, and the increasing criticality of the system integrator role positions the stock favorably. The reiterated BUY rating and ₹3,000 target reflect the potential value unlock from the sustained digital and AI-driven transformation cycle ahead.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.